Global Drug Developing Platforms by Artificial Intelligence (AI) Industry 2022, Market Growth, Size, Share, drivers, Restraints, and opportunities up to 2028 | Analysis by Top Market Players: Antidote, Atomwise, Turbine, Cambridge Cancer Genomics, and Mor

Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems.

Remarkable improvements in computational power coupled with advancements in AI technology could be utilized to revolutionize the drug development process.

Drug Developing Platforms by Artificial Intelligence (AI) Industry Research Report: A Brief Summary

• This business report provides key information on the condition of the markets for both worldwide and regional producers for businesses and anyone interested in the industry.
• This is a comprehensive study that focuses on fundamental and secondary drivers, market share, market size, leading segments, and geographical analysis.
• It also looks at issues and ideas like desire, as well as business strategies, market effectiveness, investment research, and new business difficulties.
• Tables, graphs, and charts are used to display the statistical and numerical data provided in this Drug Developing Platforms by Artificial Intelligence (AI) Industry research report, making it easier to understand statistics and facts.
• This document's market analysis also covers the market's condition, rate of progress, predicted trends, market drivers, and prospects.

Do You Want a Free Sample Copy to Explore Further? Please Click the Link Below:
https://www.reportsnreports.com/contacts/requestsample.aspx?name=6460751

Mentioned below are the prime players taken into account in this research report:
- Antidote
- Atomwise
- Turbine
- Cambridge Cancer Genomics
- Row Analytics
- Deep Genomics
- Insilico Medicine
- IBM
- Microsoft
- Google
- AiCure
- Calico
- Iktos
- GNS Healthcare
- Genpact
- Biovista
- NuMedii
- BenevolentAI
- BERG
- Schrödinge
- Nuritas
- Exscientia
- Kairntech
- Concerto HealthAI (SymphonyAI)
- NVIDIA Corporation
- Sirenas
- Standigm
- Transcriptic
- Cloud Pharmaceuticals
- Cyclica

Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Drug Developing Platforms by Artificial Intelligence (AI) Segment by Type
- Software
- System
- Service
- Product
- Others

Drug Developing Platforms by Artificial Intelligence (AI) Segment by Application
- Generate Data and Models
- Repurpose Existing Drugs
- Generate Novel Drug Candidates
- Validate and Optimize Drug Candidates
- Design Drugs
- Others

Do You Have Any Pre-Purchasing Questions? To Get Help with The Report, Kindly Click the Link Below:
https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=6460751

The readers will also get their hands on the value data of each region and country for the period 2017-2028.
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Nordic Countries
- - Rest of Europe
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- - Rest of Asia
- Latin America
- - Mexico
- - Brazil
- - Rest of Latin America
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE
- - Rest of MEA

Report Overview:

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Drug Developing Platforms by Artificial Intelligence (AI) estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Drug Developing Platforms by Artificial Intelligence (AI) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Drug Developing Platforms by Artificial Intelligence (AI) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Drug Developing Platforms by Artificial Intelligence (AI) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Drug Developing Platforms by Artificial Intelligence (AI) include Antidote, Atomwise, Turbine, Cambridge Cancer Genomics, Row Analytics, Deep Genomics, Insilico Medicine, IBM and Microsoft, etc.

In 2021, the global top five players had a share approximately % in terms of revenue.

By Purchasing Directly, You Can Save One-Fourth Off the Listed Price:
https://www.reportsnreports.com/purchase.aspx?name=6460751

Phone: +1 888 391 5441
Email: sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
We provide 24/7 online and offline support to our customers

This release was published on openPR.